A Non-Invasive and Non-Contact Jugular Venous Pulse Measurement: A Feasibility Study

Abstract

The Jugular Venous Pulse (JVP) is a vital gauge of proper heart health, reflecting the venous pressure via the Jugular Vein observation. It offers crucial insights for discerning numerous cardiac and pulmonary conditions. Yet, its evaluation is often over-shadowed by the challenges in its process, especially in patients with neck obesity obstructing visibility. Although central venous catheterization provides an alternative, it is invasive and typically reserved for critical cases. Traditional JVP monitoring methods, both visual and via catheterization, present significant hurdles, limiting their frequent application despite their clinical significance. Therefore, there is a pressing need for a non-invasive, efficient JVP monitoring method accessible for home-based and hospitalized patients. Such a method could preempt numerous hospital admissions by offering early indicators. We introduce a non-invasive method using a frequency-modulated continuous wave (FMCW) radar for JVP estimation directly from the skin surface. Our signal processing technique involves an eigen beamforming method to enhance the signal-to-noise ratio for better estimation of JVP. By meticulously fine-tuning various parameters, we identified the optimal settings to enhance the JVP signal quality. In addition, we performed a detailed morphological analysis comparing the JVP and photoplethysmography signals. Our investigation effectively achieved signal localization within a Direction of Arrival (DoA) range from -20° to 20°. This initial study validates the effectiveness of using a 60 GHz far-field radar in measuring JVP.

• Download figure
• Open in new tab

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project is supported by The Medical Research Future Fund (MRFF) Cardiovascular Health Mission grant (number: MRF2017760)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethics considerations for this study are presented to, reviewed, and approved by the Human Research Ethics Committee (HREC) at The University of Sydney under [2024/104]

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes